Contact Information
"...applications
for fast, point-of-use, SNP analysis abound in medical, emergency care,
security, education, agricultural, and veterinary industries."
Corporate Headquarters: Zerosum, Inc. 1060 Brighton Drive Seven Valleys,
PA 17360 USA
Telephone : (717) 428-9744 Toll free: (800) 672-2899
email: Contact
Zerosum Board of Directors - Zerosum is a privately held Pennsylvania C
Corporation.
Zerosum Advisors and Related Information
The
Webb Law Firm | Corporate Patent Counsel
The Webb Law Firm
One Gateway Center
420 Fort Duquesne Blvd.
Suite 200
Pittsburgh, PA 15222
http://www.webblaw.com
Dr. Stephen Holbrook - Staff scientist at Lawrence Berkeley National
Laboratory | Bioinformatics
Dr. Holbrook is an experienced macromolecular crystallographer specializing
in structural studies of RNA and Protein-nucleic acid complexes. He is currently
leading a project studying the structural basis of DNA repair in the radiation
resistant microbe Deinococcus radiodurans. He also has been involved in
computational biology projects for many years, from crystallographic computing,
to molecular modeling of nucleic acids and proteins, to machine learning
approaches to biological questions. He has developed neural networks for
the prediction of protein surface accessibility, disulfide bonding state,
and protein fold classification. He is currently developing methods for
finding novel RNA genes in genomic sequences, assignment of biological function
directly from protein sequence and classification of bacterial promoter
seqeunces.
Joseph P. Hackett - Comprehensive Wealth Management with Fulton Financial
Advisors | Financial
A firm managing $3.4 Billion in assets. Joe is responsible for Investment
Management, International - Foreign Currency, Wire Transfers, Foreign Drafts,
Estate Planning, Succession Planning and Implementation, Cash Management,
and Customized Credit options. Credit options incorporate the full spectrum
of personal and commercial needs. He has been active in these areas of financial
services for almost two decades. In addition, Mr. Hackett is active with
the YMCA, The York County Chamber of Commerce, The York Foundation, the
Strand Capital, The Cultural Alliance, Big Brothers Big Sisters, and his
church. He previously served as VP of Sales and Marketing for a regional
specialty plastics company.
Dr. Ameya S. Kantak - Technical/Biological Advisor | Life Sciences
& Bioengineering
Dr. Ameya Kantak is a seasoned healthcare professional. He joined Zerosum
in 2003 first as a bioengineer and later as an advisor. Previously he developed
Microjet patch pump at Corium International, an established transdermal
drug delivery company to deliver injectables and biotherapeutics such as
insulin painlessly through the skin. The Microjet patch-pump was widely
recognized as a breakthrough technology product by drug delivery thought
leaders and won the prestigious Edison award in the Medical Device game
changer category. He was the core member of Medtronic team that launched
world’s first breakthrough artificial pancreas technology (Minimed 530G
with Enlite Sensor) – one of a kind FDA approved PMA product for diabetes
management. He invented and published pioneering work in the areas of microfluidics,
microfabrication, sensors, analytical separations, and manufacturing methods;
and also serves as a reviewer/arbitrator of several international journals.
He earned a Ph.D. from the University of Utah. He has been instrumental
in advising engineering and manufacturing, regulatory and business aspects
of Zerosum’s core technology.
Dr. Thomas P. Sherwood - Founder Biolexia | Cognitive and Behavioral
Applications Advisor
Dr. Thomas P. Sherwood II, Cognitive and Behavioral Applications Advisor
Dr. Sherwood has 34 years experience in the field of education in both instructional
and administrative roles, with particular interest and expertise in the
area of reading disabilities. He did his undergraduate work at Penn State
University and obtained a M.Ed. from Millersville State University and an
Ed. D. from the University of Maryland. He holds two advanced state reading
certifications in Pennsylvania and one national reading certification from
post-doctoral work in a program based at Ohio State University. Upon retirement
from public education in Pennsylvania in 2006, he formed a literacy consultancy
named BioLexia. The name of the company was intentionally chosen to draw
awareness to the critical importance of acknowledging the biological substrates
impacting both the human lexicon and lexical cognitive processing in literacy
acquisition and achievement or dysfunction. BioLexia currently focuses on
educational markets regarding literacy diagnosis and intervention on three
levels: 1) University / College Student-Athletes and NCAA concerns about
APR / GSR metrics, 2) Post-secondary Technical, Training, & Trade Schools
and Community College concerns about student recruitment and retention issues,
3) Governmental / Private Business concerns for a literate workforce. Such
a focus does not exclude marketing to the multitude of private clinics,
institutes, franchises, and other educational providers dedicated to addressing
literacy concerns like dyslexia which work seeks to support, at one time
or another in their educational journey, those entering the three aforementioned
entities with underdeveloped literacy skills. Biolexia is dedicated to developing
a collaborative systems approach to the instructional interaction of mind,
brain, and education from a clinical perspective utilizing advanced diagnostic
protocols in cognition, genetics, and neurology to better inform clients'
ongoing intervention and monitoring efforts with a more "laser-like" focus
to enhance the efficacy of literacy solutions. Some of Dr Sherwood's specific
research and professional interests deemed to enable multiple synergies
with Zerosum include: 1) cortical cell genetics, 2) genetic markers for
SRD predisposition, 3) genetic etiology of SRD, 4) neural plasticity, and
5) the neurobiology of reading disabilities.